- Report
- May 2023
- 185 Pages
France
From €2619EUR$2,990USD£2,273GBP
- Report
- February 2024
- 120 Pages
North America
From €4335EUR$4,950USD£3,763GBP
- Report
- June 2023
- 150 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- August 2024
- 133 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- January 2025
- 183 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- May 2024
- 132 Pages
North America
From €3503EUR$4,000USD£3,041GBP
- Report
- November 2023
- 190 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- August 2025
- 85 Pages
India
From €3065EUR$3,500USD£2,661GBP
- Report
- November 2024
- 346 Pages
Global
From €4379EUR$5,000USD£3,801GBP
- Report
- February 2024
- 131 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- April 2023
- 110 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- February 2024
- 80 Pages
Germany
From €4160EUR$4,750USD£3,611GBP
- Report
- April 2023
- 115 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- August 2022
- 113 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- June 2025
- 250 Pages
Vietnam
From €2443EUR$2,789USD£2,120GBP
- Report
- June 2025
- 250 Pages
Saudi Arabia
From €2443EUR$2,789USD£2,120GBP
- Report
- June 2025
- 250 Pages
India
From €2443EUR$2,789USD£2,120GBP
- Report
- June 2025
- 250 Pages
Japan
From €2443EUR$2,789USD£2,120GBP
- Report
- June 2025
- 250 Pages
Brazil
From €2443EUR$2,789USD£2,120GBP
- Report
- August 2024
- 200 Pages
Global
From €4334EUR$4,949USD£3,762GBP

The Nucleic Acid Amplification (NAA) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing segment. NAA is a technique used to detect and quantify nucleic acids, such as DNA and RNA, from a variety of sources. It is used in a wide range of applications, including clinical diagnostics, food safety testing, and environmental monitoring. NAA is a highly sensitive and specific method for detecting and quantifying nucleic acids, and is increasingly being used in IVD applications.
NAA technology is used in a variety of IVD tests, including infectious disease testing, genetic testing, and cancer diagnostics. It is also used in the development of new diagnostic tests, such as those for emerging infectious diseases. NAA technology is also being used in the development of personalized medicine, allowing for the detection of genetic mutations that may be associated with certain diseases.
The NAA market is expected to continue to grow in the coming years, driven by the increasing demand for IVD tests and the development of new technologies. Major players in the NAA market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Qiagen, and Thermo Fisher Scientific. Show Less Read more